Sentence examples for use of predictive tests from inspiring English sources

The surgeons' appreciation and use of predictive tests are listed in tables 3 and 4, respectively.

The present survey showed a lack of consensus among spine surgeons on the appreciation and use of predictive tests.

Therefore, we conducted a national survey among spine surgeons in the Netherlands with the aim to assess the surgeons' opinion on prognostic patient factors known from the literature, as well as the use of predictive tests for spinal fusion in clinical practice.

In 2011, a moratorium on the use of predictive testing for insurance policies with high payouts was extended until 2017 [ 42].

A considerable heterogeneity in the use and appreciation of predictive tests was observed.

Italian public health professionals have the necessary attitudinal background to contribute to the proper use of predictive genetic testing for chronic diseases, but they need additional training to increase their methodological knowledge.

The results show that the Italian public health community has the necessary attitudinal background to contribute to the proper use of predictive genetic testing for chronic diseases, but that an additional training to increase methodological knowledge is needed.

In conclusion, the results of this survey show that the Italian public health community has the necessary attitudinal background to contribute to the proper introduction and use of predictive genetic testing for chronic diseases, but some knowledge gaps exist that should be filled through appropriate training.

There is currently a voluntary moratorium in the UK, recently extended to November 2011 (subject to review in 2008), on the use of predictive genetic test results by insurance companies when calculating premiums for life insurance policies under £500 000, critical illness and income protection under £300 000 per policy (Morrison, 2005).

Obtaining non-CSCs from an individual patient should spontaneously yield, as observed with cell lines [ 97, 98], naturally arising personalized CSCs to be used for predictive testing of an individual's response to a particular therapy.

It was concluded that although the 3 assays did not produce identical dose-response curves, the assays were equally valid when used for predictive testing because selection of cut-off points which were based on retrospective correlations between in vitro sensitivity data and response data, as established by other authors, compensated for differences in sensitivity between the assays.